#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lip and/or oral cavity cancer Stargardt's disease Ewing's sarcoma Sarcoma Polymyositis Hyperadrenocorticism Chondrosarcoma Acute respiratory distress syndrome Gestational trophoblastic tumour Paraganglion neoplasm Chorioretinitis Kawasaki's disease Bronchopulmonary aspergillosis Oesophageal adenocarcinoma Chronic myeloid leukaemia More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia Lymphangioma – Life with Disease Haemophagocytic lymphohistiocytosis – Life with Disease Hereditary neuropathic amyloidosis – Life with Disease Epidermolysis bullosa – Trials in Disease Hairy cell leukaemia recurrent – Life with Disease Optic glioma Systemic mastocytosis – Basic Information Fragile X syndrome – Trials in Disease Proteus syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Selinexor Vindesine Sulfate Onfekafusp Alfa Depemokimab SEVABERTINIB Flutamide Epoetin Alfa BMS-986470 IDP-121 Abacavir Sulfate STREPTOCOCCUS PYOGENES Mosunetuzumab Magnesium Sulfate Belatacept Ticagrelor Fludarabine Phosphate Vibosameran Afamitresgene Autoleucel Desvenlafaxine Benzoate Ibutamoren Mesilate More therapies…

    Learn about Your Condition

    Shock Haemodynamic instability Gastric cancer stage IV Cardiac failure congestive Cardiac failure acute Benign prostatic hyperplasia Left ventricular dysfunction Myocardial infarction Gaucher's disease type III Hypertrophic scar Crigler-Najjar syndrome Angiosarcoma recurrent Corticobasal degeneration Wolfram syndrome Dent's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Back pain

  • Efficacy and tolerability of diclofenac potassium + thiocolchicoside versus diclofenac potassium in patients with acute severe low back pain

    Recruiting

    3 1 1
    Investigated Drugs:
    • DICLOFENAC POTASSIUM
    • Thiocolchicoside
    • Paracetamol
    Cyprus Greece

  • Study comparing diclofenac, orphenadrine and paracetamol combination versus diclofenac alone and orphenadrine-paracetamol combination in patients with acute low back pain

    Recruiting

    3 1 1
    Investigated Drugs:
    • DICLOFENAC POTASSIUM
    • Paracetamol
    Greece

  • Study on Tricortin 1000, Diclofenac Sodium, and Paracetamol for Patients with Chronic Low Back Pain

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cyanocobalamin
    • Phospholipid From Cerebral Cortex.
    • Diclofenac Sodium
    Italy

  • Study on the Use of Platelet Concentrate and Betamethasone for Treating Chronic Low Back Pain in Patients with Lumbar Disc Degeneration

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Betamethasone Acetate
    • Platelet Concentrate
    • Betamethasone Sodium Phosphate
    Spain

  • Study of Ropivacaine and Dexamethasone Injection for Acute Low Back Pain Relief: Testing the Effectiveness of Erector Spinae Muscle Block

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ropivacaine Hydrochloride Monohydrate
    • Dexamethasone Phosphate
    France

  • Study on Opioid Detoxification Using Buprenorphine, Naloxone, and Oxycodone for Patients with Persistent Spinal Pain Syndrome Type II

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Clonidine Hydrochloride
    • Buprenorphine
    • Naloxone
    Belgium
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!